Hazardous Materials Supply for Naval Hospital Guam
ID: HT941025Q2093Type: Combined Synopsis/Solicitation
Overview

Buyer

DEPT OF DEFENSEDEFENSE HEALTH AGENCY (DHA)DEFENSE HEALTH AGENCYFALLS CHURCH, VA, 22042, USA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

LABORATORY EQUIPMENT AND SUPPLIES (6640)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)
Timeline
    Description

    The Department of Defense, through the Defense Health Agency, is seeking qualified small businesses to provide hazardous materials supplies for the U.S. Naval Hospital Guam. The procurement includes Point of Care reagents, Cytology/Histology reagents, bacteriology supplies, hematology stains, and medical drug screen reagents, which are essential for the hospital's operational needs. This contract is significant as it ensures the availability of critical laboratory supplies necessary for patient care and diagnostic services at the facility. Interested vendors must submit their quotations by 10 AM Pacific on August 20, 2025, and can direct inquiries to Kennette Esguerra at kennette.m.esguerra.civ@health.mil or Tracy Robinson at tracy.m.robinson18.civ@health.mil.

    Files
    Title
    Posted
    Amendment 0001 to Solicitation HT941025Q2093, issued on 8 August 2025, addresses questions regarding the Hazardous Materials Supply contract for Naval Hospital Guam. The primary purpose of this amendment is to clarify whether the contract is new or a continuation of an existing service. The government's response confirms that the previous contractor was International Hospital Supply Corporation, under contract number N6809623P0022. All other terms and conditions of the original solicitation remain unchanged. The amendment emphasizes that all submitted quotes must acknowledge all amendments to the solicitation.
    AMENDMENT 0002 to SOLICITATION HT941025Q2093 for HAZARDOUS MATERIALS SUPPLY FOR NAVAL HOSPITAL GUAM extends the quotation due date from August 14, 2025, to August 20, 2025, at 10 AM Pacific. All other terms and conditions of the solicitation remain unchanged. Quoters are reminded that their submittal must include acknowledgment of all amendments to this solicitation.
    This Statement of Work (SOW) outlines the requirements for procuring various reagents and supplies, including Point of Care, Cytology/Histology, bacteriology, hematology stains, and medical drug screen reagents, for the U.S. Naval Hospital Guam. The contractor must supply commercially available items with a minimum 12-month shelf life upon arrival, conforming to industry standards and manufacturer specifications. Key delivery requirements include shipping hazardous materials via ocean freight and blood culture bottles via UPS air freight to the Naval Hospital Guam within 15 days of contract award. All items are subject to government inspection upon receipt, with non-conforming items subject to replacement. The SOW also details invoicing procedures and provides contact information for government and payment acceptance personnel.
    The document is a Quotation Sheet for Solicitation Number HT941025Q2093, detailing a requirement for Hazmat Supplies at Naval Hospital Guam. The contracting office is the Defense Health Agency Contracting Activity (DHACA), Healthcare Contracting Division - West (HCD-W). Quotations must be received by 10 AM Pacific on Thursday, August 14, 2025. The delivery period spans from October 1, 2025, to September 30, 2030, broken down into a base period and four option periods (Option 1: 2027, Option 2: 2028, Option 3: 2029, Option 4: 2030). Each period lists various hazardous materials, including stains, blood culture media, and other lab supplies, with their corresponding CLINS, delivery dates, and quantities. The document also includes sections for the offeror's information, payment terms, and acknowledgment of amendments.
    The document is a Quotation Sheet for Solicitation Number HT941025Q2093, detailing a requirement for Hazmat Supplies at Naval Hospital Guam. The contracting office is the Defense Health Agency Contracting Activity (DHACA), Healthcare Contracting Division - West (HCD-W). Quotations must be received by 10 AM Pacific on Thursday, August 14, 2025. The delivery period spans from October 1, 2025, to September 30, 2030, broken down into a base period and four option periods (Option 1: 2027, Option 2: 2028, Option 3: 2029, Option 4: 2030). Each period lists various hazardous materials, including stains, blood culture media, and other lab supplies, with their corresponding CLINS, delivery dates, and quantities. The document also includes sections for the offeror's information, payment terms, and acknowledgment of amendments.
    The Statement of Work (SOW) outlines the procurement requirements for the U.S. Naval Hospital Guam, focusing on acquiring commercial supplies including Point of Care reagents, Cytology/Histology reagents, bacteriology supplies, and medical drug screen reagents. This acquisition is essential for maintaining high-quality patient care for both active duty and civilian populations at the hospital, reflecting a reliance on past vendor performance. The contractor must provide items that are commercially available, have a minimum shelf life of 12 months, and ship in appropriate conditions to ensure product integrity. Key delivery requirements stipulate that items must arrive within 15 days post-award, with partial shipments accepted under government approval. The inspection and acceptance process allows the government to reject non-conforming items and requires warranties for compliance. Invoicing guidelines mandate that invoices reference the contract number, with payment processing contingent on the government’s acceptance of the goods. Points of contact for government management are provided, ensuring clear communication between the contractor and the hospital. The document serves as a formal request for proposals (RFP), reflecting the federal process for procurement in support of healthcare operations.
    The document outlines a Request for Proposal (RFP) for medical supplies, specifically providing a detailed list of items needed by the Naval Hospital Guam under a contracting initiative by the Defense Health Agency. The RFP includes various delivery timelines, with quantities ranging from 1 to 60 units for each item, with delivery dates extending from September 30, 2026, to September 30, 2030. The supplies requested encompass essential medical items such as blood culture media, blood gas testing kits, Gram stain kits, and various staining solutions. The document specifies the solicitation number, the bidding deadline for quotations, and the contracting office responsible for managing the procurement process. Furthermore, it outlines that all offers must remain valid for a specified duration and requires acknowledgment of any amendments made to the solicitation. This RFP reflects the government's ongoing efforts to secure critical medical supplies for healthcare support in military settings, emphasizing the importance of timely procurement and compliance with federal regulations.
    The document outlines a solicitation for hazmat supplies at the Naval Hospital Guam, facilitated by the Defense Health Agency Contracting Activity (DHACA). The requirement spans from October 1, 2025, to September 30, 2030, with quotations due by August 14, 2025. It details specific line items, including various laboratory supplies such as xylene, mounting mediums, blood gas testing kits, and staining solutions. The list is organized by delivery years with the base year for 2026 and options extending through 2030. Each item includes the quantity, unit type, and projected delivery date. The total evaluated price is currently listed as $0.00, pending valid quotations. Additionally, potential vendors must complete details including their address, point of contact, and acknowledgment of amendments to the solicitation. This RFP highlights the federal government's ongoing need for essential medical supplies in healthcare facilities and the structured procurement process to meet those needs.
    This document is a Request for Quote (RFQ) for the supply of Point of Care, Cytology/Histology, bacteriology, hematology, and medical drug screen reagents to support the U.S. Naval Hospital Guam (NHG). The solicitation, HT941025Q2093, is 100% set aside for small businesses, with a NAICS Code of 325413 and a size standard of 1,250 employees. It outlines detailed requirements for base year and four optional years of supply, with specific delivery dates for each CLIN. Key instructions for offerors include electronic submission of quotes in PDF format, a two-page capabilities statement, OEM certification or authorized distributor/reseller letters, and descriptive literature for 'equal' products. Quotes must include a completed Attachment 2 (Quote Sheet) with firm-fixed-prices for all items. Evaluation will be based on Technical Capability (Acceptable/Unacceptable), Delivery Requirement (more important than price, assessed via SPRS records), and Price Reasonableness. Offerors must be registered in SAM with appropriate NAICS codes and complete FAR provision 52.204-24. Quotes are due by 10:00 AM Pacific on August 14, 2025, with questions due by August 7, 2025.
    The document is a Request for Quote (RFQ) from the Defense Health Agency, seeking small business suppliers for medical and laboratory reagents and supplies for U.S. Naval Hospital Guam. It outlines the requirement for various items, including point-of-care reagents, bacteriology supplies, and medical drug screen reagents, with delivery dates extending from 2026 to 2030. The RFQ emphasizes compliance with federal acquisition regulations, including the need for contractors to provide evidence of being an original equipment manufacturer or authorized distributor. Key evaluation factors for valid bids include technical capability, delivery requirements, and pricing. Additionally, it stresses the importance of vendors' recent and relevant delivery performances as a measure of reliability. Compliance with outlined FAR and DFARS provisions regarding telecommunications equipment, contractor ethics, and other regulatory requirements is mandatory. The detailed instructions for submissions, including specifications for electronic submissions, completion of certain provisions, and a definitive deadline for quote submissions are specified. Overall, the RFQ aims to establish a fair and competitive procurement process for critical medical supplies while meeting federal regulations.
    Lifecycle
    Title
    Type
    Combined Synopsis/Solicitation
    Similar Opportunities
    Chemistry Analyzers for Naval Hospital Yokosuka
    Buyer not available
    The Department of Defense, through the Defense Health Agency, is seeking to procure five chemistry analyzers for the Naval Hospital Yokosuka in Japan. The analyzers must meet specific technical requirements, including a Laboratory Information System with bidirectional interface capabilities, the ability to process various sample types, and features for critical value notifications, among others. These analyzers are crucial for efficient laboratory operations, enabling the hospital to manage a high volume of samples—up to 100,000 annually—while ensuring timely and accurate diagnostics. Interested vendors can reach out to Cassi Jo Newman at cassi.j.newman.civ@health.mil or Jeffrey Collins at JEFFREY.P.COLLINS20.CIV@HEALTH.MIL for further details.
    Beckman Coulter Hematology Analyzers and Reagents for Naval Hospitals Yokosuka and Okinawa
    Buyer not available
    The Department of Defense, through the Defense Health Agency, is seeking to procure nine hematology analyzers and associated reagents for Naval Hospitals located in Yokosuka and Okinawa, Japan, as well as Branch Health Clinics in Atsugi, Sasebo, Iwakuni, Japan, and Diego Garcia, United Kingdom. These analyzers are critical for conducting Complete Blood Counts and other hematology tests, ensuring timely and accurate results for blood samples that cannot be transported over long distances without compromising their integrity. The contract requires that the analyzers be delivered, installed, and validated by January 1, 2023, and interested vendors can reach out to primary contact Cassi Jo Newman at cassi.j.newman.civ@health.mil or secondary contact Jeff Collins at jeffrey.p.collins20.civ@health.mil for further details.
    Immunohematology Blood-Grouping Analyzer Cost Per Test Contract (GSA eBuy)
    Buyer not available
    The Department of Defense, through the Defense Health Agency, is seeking proposals for a Cost Per Test (CPT) contract to supply two automated immunohematology blood-grouping analyzers for the Naval Medical Center Portsmouth (NMCP). The contract includes the provision of analyzers, reagents, quality control materials, maintenance services, and consumables necessary for the Transfusion Services Division, which plays a critical role in ensuring safe and timely blood transfusions for patients. The analyzers must meet specific testing capabilities, including ABO/Rh typing and antibody screening, and comply with FDA and other regulatory standards, with a delivery period set from January 1, 2026, to December 31, 2026. Interested vendors must submit their quotations via GSA eBuy by December 9, 2025, at 10:00 p.m. ET, and all inquiries should be directed to Matthew Teel at matthew.d.teel.civ@health.mil.
    Reagents, Stains, and other Laboratory Supplies
    Buyer not available
    The Indian Health Service (IHS) is conducting market research to identify potential sources for the procurement of reagents, stains, and other laboratory supplies for the Inscription House Health Center located in Shonto, Arizona. This sources sought notice aims to gather information from interested parties to inform the contracting office's acquisition strategy, including considerations for competition and set-asides, particularly for Indian-owned economic enterprises. The selected suppliers will play a crucial role in supporting healthcare services within the community by providing essential laboratory supplies. Interested vendors are invited to submit their qualifications and capabilities by December 15, 2025, at 1:00 pm EDT to Charity Yellowhair-Gilbert at charity.yellowhair-gilbert@ihs.gov, ensuring they are registered in the System for Award Management (SAM) and include necessary documentation, including the IHS IEE Representation Form if applicable.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/ Uniform Formulary Additional Discount Program
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), is soliciting quotes for a Blanket Purchase Agreement (BPA) and an Additional Discount Program (ADP) for pharmaceutical agents to be included in the DoD Uniform Formulary (UF). This procurement aims to establish an effective pharmacy benefits program for the Military Health System (MHS), focusing on oncological agents for myelofibrosis and antihemophilic agents, with evaluations based on clinical and cost-effectiveness. Interested vendors must submit their quotes by January 16, 2026, with a pre-quotation teleconference scheduled for November 20, 2025. For further inquiries, contact Tracy Banks at tracy.e.banks2.civ@health.mil or Stephanie Erpelding at stephanie.j.erpelding.civ@health.mil.
    Coagulation Analyzers for Naval Hospital Yokosuka and Branch Clinic Iwakuni
    Buyer not available
    The Department of Defense, through the Defense Health Agency, is seeking to procure three coagulation analyzers and associated reagents for the Naval Hospital Yokosuka and Branch Clinic Iwakuni in Japan. The analyzers must meet specific technical requirements, including Laboratory Information System connectivity, a Windows 11 user interface, and the capability to perform various coagulation tests, while adhering to size and power limitations due to laboratory constraints. These analyzers are critical for ensuring timely and accurate diagnostic capabilities in a military healthcare setting. Interested vendors should contact Cassi Jo Newman at cassi.j.newman.civ@health.mil or Jeff Collins at jeffrey.p.collins20.civ@health.mil for further details, with a delivery, installation, and validation deadline set for July 1, 2023.
    NBG Security Department_Portable Toilets_GUAM
    Buyer not available
    The Department of Defense, through the Naval Supply Fleet Logistics Center Yokosuka, is soliciting quotes for the provision of portable toilets for the Naval Base Guam Security Department. The contract requires the delivery and servicing of 12 deluxe portable toilets, including regular cleaning, sanitizing, and replenishing supplies, with a base performance period from December 17, 2025, to December 16, 2026, and four optional one-year extensions through December 16, 2030. This service is crucial for maintaining sanitation and hygiene standards at military installations. Interested small businesses must submit their quotations by December 11, 2025, to the designated contract specialists, with further details available in the solicitation documents.
    6550--Triage Meterpro Reagents
    Buyer not available
    The Department of Veterans Affairs (VA) is seeking qualified sources to provide QuidelOrtho Triage MeterPro Reagents for the New Mexico VA Healthcare System, through a Sources Sought Notice (RFI 36C26226Q0177). The procurement aims to acquire various medical diagnostic and drug testing supplies, including Triage Tox DS Panels, Controls, and BNP Test Kits, which are essential for accurate drug testing and patient care. Interested vendors are encouraged to submit their capabilities, pricing, and relevant business information by December 8, 2025, at 10:00 a.m. PST, to the Contract Specialist, Clift Domen, at Clift.Domen@va.gov.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Buyer not available
    The Department of Defense (DoD) is soliciting quotes for pharmaceutical agents as part of its Uniform Formulary Blanket Purchase Agreement (UF BPA) and Uniform Formulary Additional Discount Program (UF ADP) through the Defense Health Agency (DHA). This procurement aims to establish an effective pharmacy benefits program for the Military Health System (MHS), focusing on the clinical and cost-effectiveness of drugs to determine their classification within the formulary. The P&T Committee will review newly approved drugs, including agents for pulmonary, gynecological, endocrine, atopy, skeletal muscle relaxants, and pain management, with quotes due by December 9, 2025, ahead of the committee meeting scheduled for February 4-5, 2026. Interested manufacturers should contact Stephanie Erpelding or Tracy Banks for further details and ensure compliance with submission requirements outlined in the RFQ HT9402-26-Q-9102.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Buyer not available
    The Department of Defense, through the Defense Health Agency, is soliciting quotes for the Pharmacy Uniform Formulary Blanket Purchase Agreement and the Uniform Formulary Additional Discount Program, aimed at establishing an effective pharmacy benefits program for the Military Health System. This procurement involves the evaluation and selection of pharmaceutical agents based on their clinical and cost-effectiveness, with a focus on newly approved drugs that will be reviewed by the Pharmacy and Therapeutics Committee in February 2025. Interested vendors must submit their pricing information, including National Drug Codes (NDCs), by December 19, 2024, and are encouraged to participate in a pre-quotation teleconference on December 4, 2024. For further inquiries, vendors can contact Tracy Banks at tracy.e.banks2.civ@mail.mil or Julia Trang at julia.n.trang.civ@health.mil.